Effects of Longyanshen polysaccharides on free radical metabolism in senescence accelerated-prone mice

Neural Regeneration Research

Volumn 3, Issue 10, 2008, Pages 1099-1102

  Huang, Zhongshi ^a,b   Xie, Haiyuan ^b   Zhang, Shijun ^b   Jiao, Yang ^b   Jiang, Weizhe ^b   Huang, Renbin ^b  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b YOUJIANG MEDICAL COLLEGE FOR NATIONALITIES   (China)

Author keywords

Free radical; Glutathione peroxidase; Longyanshen polysaccharides; Malonaldehyde; Mice; Nitric oxide; Senescence accelerated prone; Superoxide dismutase

Indexed keywords

CHINESE DRUG; FREE RADICAL; GLUTATHIONE PEROXIDASE; LONGYANSHEN; MALONALDEHYDE; NITRIC OXIDE; POLYSACCHARIDE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DEMENTIA; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MECHANISM; DRUG MEGADOSE; ENZYME ACTIVITY; FEMALE; LOW DRUG DOSE; MALE; MEMORY; MOUSE; NONHUMAN; OXIDATIVE STRESS; SENESCENCE; SENESCENCE ACCELERATED MOUSE; SPECTROPHOTOMETRY; TISSUE LEVEL;

EID: 69749118721     PISSN: 16735374     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Markesbery WR. Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 1997;23(1):134-47
2. Moreira PI, Santos MS, Oliveira CR, et al. Alzheimer disease and the role of free radicals in the pathogenesis of the disease. CNS Neurol Disord Drug Targets 2008;7(1):3-10
3. Dubinina EE, Pustygina AV. Free radical processes in aging, neurodegenerative diseases and other pathological states. Biomed Khim 2007;53(4):351-72
4. Zhu X, Su B, Wang X, et al. Causes of oxidative stress in Alzheimer disease. Cell Mol Life Sci 2007;64(17):2202-10
5. Carney JM, Carney AM. Role of protein oxidation in aging and in age-associated neurodegenerative diseases. Life Sci 1994;55(25-26):2097-103
6. Markesbery WR, Lovell MA. Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment. Arch Neurol 2007;64(7):954-6
7. Shi Q, Gibson GE. Oxidative stress and transcriptional regulation in Alzheimer disease. Alzheimer Dis Assoc Disord 2007;21(4):276-91
8. Hall ED, Andrus PK. Measurement of oxygen radicals and lipid peroxidation in neural tissues. Curt Protoc Neurosci 2000;Chapter 7:Unit7.17
9. Casado A, Encarnaciǒn Lǒpez-Fernňdez M, Concepciǒn Casado M, et al. Lipid peroxidation and antioxidant enzyme activities in vascular and Alzheimer dementias. Neurochem Res 2008;33(3):450-8
10. Huang X, Moir RD, Tanzi RE, et al. Redox-active metals, oxidative stress, and Alzheimer's disease pathology. Ann N Y Acad Sci 2004;1012:153-63
11. Wu ZZ, Zhang YP, Wang HL, et al. Ultrastructural quantitative study on BUGAN YANGSUI formula on synaptic plasticity of molecular layer of hippocampal CA1 region in spontaneous Alheimer disease mice. Zhongguo Zhongyiyao Keji 2007;4(6):442-4
12. Halliwell B. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 2001;18(9):685-716
13. Nunomura A, Moreira PI, Takeda A, et al. Oxidative RNA damage and neurodegeneration. Curr Med Chem 2007;14(28):2968-75
14. Pratt RC, Stack TD. Intramolecular charge transfer and biomimetic reaction kinetics in galactose oxidase model complexes. J Am Chem Soc 2003;125(29):8716-7
15. Song X, Bao M, Li D, et al. Advanced glycation in D-galactose induced mouse aging model. Mech Ageing Dev 1999;108(3):239-51
16. Zablocka A, Janusz M. The two faces of reactive oxygen species. Postepy Hig Med Dosw (Online) 2008;62:118-24
17. Fusco D, Colloca G, Lo Monaco MR, et al. Effects of antioxidant supplementation on the aging process. Clin Interv Aging 2007;2(3):377-87
18. Richardson JS. Free radicals in the genesis of Alzheimer's disease. Ann N Y Acad Sci 1993;695:73-6
19. Manczak M, Anekonda TS, Henson E, et al. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum Mol Genet 2006;15(9):1437-49
20. Ouyang S, Sun LS, Guo SL, et al. Effects of timosaponins on learning and memory abilities of rats with dementia induced by lateral cerebral ventricular injection of amyloid beta-peptide. Dr Yi Jun Yi Da Xue Xue Bao 2005;25(2):121-6
21. Zhang YL, Zhang WJ, He QH. Removal of protein from the crude persimmon polysaccharides by proteases-Sevag's method. Shipin Gongye Keji 2005;26(5):107
22. Kong XL, Jiang WZ, Lin ZZ. Effect of Extract of Longyanshen on immunodepression induced by cyclophosphamide in mice. Zhongguo Yaofang 2004;15(6):335-6
23. Jiang WZ, Kong XL, Huang RB, et al. Protective effects and mechanisms of Longyanshen on acute chemical liver injury in mice. Zhongguo Yaofang 2004;15(7):398-400
24. Zhou LZ, Yang XL, Zhou JY, et al. Advances of the antioxidative activities research of polysaccharides. Zhongguo Shenghua Yaowu Zazhi 2002;23(4):210
25. Chelvarajan RL, Collins SM, Van Willigen JM, et al. The unresponsiveness of aged mice to polysaccharide antigens is a result of a defect in macrophage function. J Leukoc Biol 2005;77(4):503-12
26. Lee JM, Kwon H, Jeong H, et al. Inhibition of lipid peroxidation and oxidative DNA damage by Ganoderma lucidum. Phytother Res 2001;15(3):245-9
27. Huang ZS, Huang RB, Li J, et al. The effects of LongYanShen polysaccharide on mouse memory function in different mouse dementia models. Youjiang Minzu Yixueyuan Xuebao 2004;26(4):463-4
28. Wu MD, Kimura M, Inafuku S, et al. Effect of aging on the expression, NOS and cell death in the mouse cochlear spiral agnglion. Okajimas Folia Anat Jpn 1997;74(5):155
29. Chirino YI, Orozco-Ibarra M, Pedraza-Chaverri J. Role of peroxynitrite anion in different diseases. Rev Invest Clin 2006;58(4):350-8
30. Malinski T. Nitric oxide and nitroxidative stress in Alzheimer's disease. J Alzheimers Dis 2007;11(2):207-18
31. Li P, He HR, Chen QS, et al. Effects of melatonin on NO, NOS, SOD, MDA and Lipofuscin level in brain tissue of aging model mice induced by D-galactose. Jichu Yixue yu Linchuang 2002;22(3):275
32. Corzo L, Zas R, Rodriguez S, et al. Decreased levels of serum nitric oxide in different forms of dementia. Neurosci Lett 2007;420(3):263-7
33. Hollenberg NK. Organ systems dependent on nitric oxide and the potential for nitric oxide-targeted therapies in related diseases. J Clin Hypertens (Greenwich) 2006;8(12 Suppl 4):63-73